Apothékary key facts
- Operator of a herbal medicine company intended to offer clean, natural alternatives to over-the-counter drugs and supplements.
- Apothékary’s last known valuation is $290.0M.
- It has raised $18.7M; the latest was Seed Round ($10.0M) in Nov 2024.
- Notable investors include Trousdale Ventures, Venrex Investment Management, The Venture Collective, Meach Cove Capital, Stella Capital (Chicago) — 20 tracked in total.
- Status: Privately Held (backing).
Who backs Apothékary
20+- ·The complete investor list: 20 names
- ·Watch Apothékary: the Monday email on marks, rounds and moves
Apothékary funding rounds
No funding rounds for Apothékary are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Apothékary valuation
Apothékary's last known valuation is $290 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
Apothékary investors
20 investors are on record for Apothékary, including Trousdale Ventures, Venrex Investment Management, The Venture Collective and Meach Cove Capital. By type, the record holds 6 venture capital firms, 1 family office and 1 angel investor.
About Apothékary
Operator of a herbal medicine company intended to offer clean, natural alternatives to over-the-counter drugs and supplements. The company offers herbal plant-based medicines that are natural, sustainable, and ethically sourced, enabling consumers to purchase natural alternatives to drugs at affordable prices.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Falls Church, VA, United States
- Founded
- 2018
- Employees
- 51
- Website
- apothekary.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Apothékary’s last known valuation. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.